Sleep Apnea Screening for Diabetics – SleepXpert Program
- On October 8, 2024, SMD100 launched the "SleepXpert Program," a new initiative focused on identifying and addressing sleep apnea among individuals living with diabetes.
- People with diabetes are substantially more likely to develop sleep apnea, a disorder characterized by pauses in breathing during sleep.
- The connection between type 2 diabetes and obstructive sleep apnea (OSA) is well-established.
New Program Aims to Tackle Sleep Apnea in Diabetic Patients
Table of Contents
On October 8, 2024, SMD100 launched the “SleepXpert Program,” a new initiative focused on identifying and addressing sleep apnea among individuals living with diabetes. This program represents a notable step toward improving the health outcomes of a population at heightened risk for this often-undiagnosed condition.
The Link Between Diabetes and Sleep Apnea
The connection between type 2 diabetes and obstructive sleep apnea (OSA) is well-established. According to research published in the journal Diabetes Care, up to 80% of people with type 2 diabetes also have sleep apnea (“Sleep Apnea and Insulin resistance”). Several factors contribute to this association, including obesity, which is a common risk factor for both conditions, and shared metabolic pathways.
how the SleepXpert Program Works
The SleepXpert Program is designed to proactively screen diabetic patients for sleep apnea. Details regarding the specific screening methods employed by the program were not promptly available, but generally, screening can involve questionnaires assessing daytime sleepiness and breathing patterns during sleep, as well as home sleep apnea tests (HSATs) (“Sleep Apnea Tests”). HSATs allow patients to be monitored for sleep apnea in the comfort of their own homes, providing a convenient and accessible diagnostic option.
“Early diagnosis and treatment of sleep apnea can significantly improve glycemic control and reduce cardiovascular risk in patients with diabetes.”
The Benefits of Early Detection and Treatment
Treating sleep apnea in diabetic patients can lead to substantial health improvements. Continuous positive airway pressure (CPAP) therapy, a common treatment for OSA, has been shown to improve insulin sensitivity, lower blood pressure, and reduce the risk of cardiovascular events (“Sleep Apnea”). Furthermore, addressing sleep apnea can enhance energy levels, improve cognitive function, and overall quality of life.
The launch of the SleepXpert Program by SMD100 underscores a growing recognition of the importance of integrated healthcare approaches that address the interconnectedness of chronic conditions.by prioritizing sleep health, SMD100 aims to empower diabetic patients to take control of their health and well-being.